Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LQDA
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect | 148,818 Added 19.25% |
$1,636,998
$11.0 p/Share
|
Jul 30
2018 |
|
LQDA
|
Glaxosmithkline PLC |
BUY
Conversion of derivative security
|
Indirect | 455,111 Added 30.7% |
-
|
Jul 30
2018 |
|
HON
|
Linnet F Deily
Director |
SELL
Open market or private sale
|
Direct | 3,066 Reduced 26.01% |
$484,796
$158.12 p/Share
|
Jul 30
2018 |
|
HON
|
Linnet F Deily
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,028 Added 29.9% |
$302,334
$60.13 p/Share
|
Jul 30
2018 |
|
MDT
|
Michael J Coyle
EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct | 16,465 Added 8.6% |
-
|
Jul 30
2018 |
|
MDT
|
Hooman Hakami
EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct | 9,355 Added 12.34% |
-
|
Jul 30
2018 |
|
MDT
|
Omar Ishrak
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 50,517 Added 7.9% |
-
|
Jul 30
2018 |
|
MDT
|
Richard Kuntz
SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct | 10,104 Added 7.99% |
-
|
Jul 30
2018 |
|
MDT
|
Bradley E Lerman
SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct | 11,226 Added 15.03% |
-
|
Jul 30
2018 |
|
MDT
|
Geoffrey Martha
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 11,226 Added 14.93% |
-
|
Jul 30
2018 |
|
MDT
|
Karen L Parkhill
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 14,089 Added 14.92% |
-
|
Jul 30
2018 |
|
MDT
|
Carol A Surface
EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,233 Added 15.0% |
-
|
Jul 30
2018 |
|
MDT
|
Hoedt Rob Ten
EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct | 9,730 Added 12.04% |
-
|
Jul 30
2018 |
|
MDT
|
Robert John White
EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct | 10,478 Added 16.75% |
-
|
Jul 30
2018 |
|
INTC
|
Andy D Bryant
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 1,114 Reduced 0.26% |
$52,592
$47.21 p/Share
|
Jul 30
2018 |
|
INTC
|
Andy D Bryant
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,302 Added 0.53% |
-
|
Jul 30
2018 |
|
INTC
|
Kevin Thomas Mc Bride
VP Finance, Corp. Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 104 Reduced 0.75% |
$4,910
$47.21 p/Share
|
Jul 30
2018 |
|
INTC
|
Kevin Thomas Mc Bride
VP Finance, Corp. Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 309 Added 2.19% |
-
|
Jul 30
2018 |
|
INTC
|
Venkata S M Renduchintala
Group President (TSCG) |
SELL
Payment of exercise price or tax liability
|
Direct | 1,461 Reduced 3.88% |
$68,974
$47.21 p/Share
|
Jul 30
2018 |
|
INTC
|
Venkata S M Renduchintala
Group President (TSCG) |
BUY
Exercise of conversion of derivative security
|
Direct | 2,946 Added 7.25% |
-
|
Jul 30
2018 |
|
INTC
|
Steven Ralph Rodgers
EVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 6,940 Reduced 21.14% |
$327,637
$47.21 p/Share
|
Jul 30
2018 |
|
INTC
|
Steven Ralph Rodgers
EVP General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 13,995 Added 30.85% |
-
|
Jul 30
2018 |
|
DHR
|
Thomas Patrick Joyce Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 94,624 Reduced 34.23% |
$9,637,454
$101.85 p/Share
|
Jul 30
2018 |
|
DHR
|
Thomas Patrick Joyce Jr
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 94,624 Added 25.5% |
$3,827,541
$40.45 p/Share
|
Jul 30
2018 |
|
DHR
|
Thomas Patrick Joyce Jr
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,613 Reduced 5.29% |
$978,700
$101.81 p/Share
|
Jul 30
2018 |
|
KO
|
Ahmet Muhtar Kent
Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 1,198,347 Reduced 41.18% |
$55,243,795
$46.1 p/Share
|
Jul 30
2018 |
|
KO
|
Ahmet Muhtar Kent
Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 1,750,000 Added 37.55% |
$37,800,001
$21.6 p/Share
|
Jul 30
2018 |
|
PEN
|
James Robert Pray
President, International |
SELL
Open market or private sale
|
Indirect | 8,125 Reduced 0.32% |
$1,121,737
$138.06 p/Share
|
Jul 30
2018 |
|
R
|
Art A Garcia
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,412 Reduced 21.32% |
$262,110
$76.82 p/Share
|
Jul 30
2018 |
|
R
|
Art A Garcia
EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,412 Added 17.4% |
$182,986
$53.63 p/Share
|
Jul 30
2018 |
|
TRU
|
Gerald M Mc Carthy Jr
EVP - Healthcare |
SELL
Open market or private sale
|
Direct | 62,752 Reduced 62.88% |
$4,430,919
$70.61 p/Share
|
Jul 30
2018 |
|
TRU
|
Gerald M Mc Carthy Jr
EVP - Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct | 62,752 Added 38.7% |
$819,541
$13.06 p/Share
|
Jul 30
2018 |
|
SFNC
|
Russell William Teubner |
SELL
Open market or private sale
|
Direct | 1,410 Reduced 48.49% |
$42,441
$30.1 p/Share
|
Jul 30
2018 |
|
SFNC
|
Russell William Teubner |
SELL
Open market or private sale
|
Indirect | 662 Reduced 100.0% |
$19,959
$30.15 p/Share
|
Jul 30
2018 |
|
BRY
|
Oaktree Capital I, L.P.
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 410,229 Reduced 5.07% |
$5,398,614
$13.16 p/Share
|
Jul 30
2018 |
|
BRY
|
Benefit Street Partners LLC
> 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 1,391,967 Reduced 7.43% |
$18,318,286
$13.16 p/Share
|
Jul 30
2018 |
|
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.46% |
$2,284,000
$45.68 p/Share
|
Jul 30
2018 |
|
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 91,205 Added 0.84% |
$3,749,438
$41.11 p/Share
|
Jul 30
2018 |
|
ASB
|
Philip B Flynn
President & CEO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 1.84% |
$277,500
$27.75 p/Share
|
Jul 30
2018 |
|
TENB
|
Insight Holdings Group, LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 14,181,722 Added 50.0% |
-
|
Jul 30
2018 |
|
TENB
|
Insight Holdings Group, LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 14,183,155 Added 50.0% |
-
|
Jul 30
2018 |
|
AROW
|
Raymond F O'Conor
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.15% |
$38,890
$38.89 p/Share
|
Jul 30
2018 |
|
UNP
|
Lance M Fritz
CHAIRMAN PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 38,637 Reduced 7.54% |
$5,739,913
$148.56 p/Share
|
Jul 30
2018 |
|
UNP
|
Lance M Fritz
CHAIRMAN PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 49,566 Added 8.82% |
$4,339,999
$87.56 p/Share
|
Jul 30
2018 |
|
INTC
|
Robert Holmes Swan
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,461 Reduced 2.04% |
$68,974
$47.21 p/Share
|
Jul 30
2018 |
|
INTC
|
Robert Holmes Swan
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,946 Added 3.95% |
-
|
Jul 30
2018 |
|
INTC
|
Robert Holmes Swan
CEO |
BUY
Open market or private purchase
|
Direct | 5,243 Added 6.5% |
$250,039
$47.69 p/Share
|
Jul 30
2018 |
|
NKE
|
Monique S. Matheson
EVP: CHRO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.52% |
$760,700
$76.07 p/Share
|
Jul 30
2018 |
|
NKE
|
Monique S. Matheson
EVP: CHRO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 10.33% |
$172,400
$17.24 p/Share
|
Jul 30
2018 |
|
ABT
|
Sharon J Bracken
Senior Vice President |
SELL
Open market or private sale
|
Direct | 615 Reduced 1.49% |
$40,073
$65.16 p/Share
|
Jul 30
2018 |